XNAS 28 Apr, 2026 10:20 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Myriam J. Curet | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 229.39 per share. | 10 Mar 2026 | 105 | 105 (0%) | 0% | 229.4 | 24,086 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 105 | 1,152 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriam J. Curet | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 493.95 per share. | 10 Mar 2026 | 105 | 0 (0%) | 0% | 494.0 | 51,865 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 490.19 per share. | 06 Mar 2026 | 648 | 2,258 (0%) | 0% | 490.2 | 317,643 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 485.01 per share. | 06 Mar 2026 | 645 | 1,613 (0%) | 0% | 485.0 | 312,831 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 498.68 per share. | 03 Mar 2026 | 2,362 | 3,554 (0%) | 0% | 498.7 | 1,177,883 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 488.10 per share. | 03 Mar 2026 | 648 | 5,916 (0%) | 0% | 488.1 | 316,289 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 495.20 per share. | 03 Mar 2026 | 648 | 2,906 (0%) | 0% | 495.2 | 320,890 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 487.18 per share. | 02 Mar 2026 | 4,728 | 409 (0%) | 0% | 487.2 | 2,303,387 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 492.59 per share. | 02 Mar 2026 | 125 | 5,137 (0%) | 0% | 492.6 | 61,574 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 208.90 per share. | 02 Mar 2026 | 125 | 5,262 (0%) | 0% | 208.9 | 26,113 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary S. Guthart | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 1,243 | 10,514 (0%) | 0% | 503.5 | 625,863 | Common Stock |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 2,506 | 11,757 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 26,334 | 0 | - | - | Performance Stock Units - 2-28-2023 | |
| Gary S. Guthart | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 13,059 | 23,789 (0%) | 0% | 503.5 | 6,575,337 | Common Stock |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 26,334 | 36,848 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 2,506 | 0 | - | - | Restricted Stock Units | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 752 | 0 | - | - | Restricted Stock Units | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 10,773 | 0 | - | - | Performance Stock Units - 2-28-2023 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 5,343 | 15,366 (0%) | 0% | 503.5 | 2,690,254 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 10,773 | 20,709 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 373 | 9,936 (0%) | 0% | 503.5 | 187,809 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 752 | 10,309 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 1,503 | 234,151 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 14,363 | 247,768 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 7,122 | 240,646 (0%) | 0% | 503.5 | 3,585,998 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 9,052 | 0 | - | - | Performance Stock Units - 6-12-2023 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 9,052 | 249,698 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 1,503 | 0 | - | - | Restricted Stock Units | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 4,489 | 245,209 (0%) | 0% | 503.5 | 2,260,256 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 14,363 | 0 | - | - | Performance Stock Units - 2-28-2023 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 746 | 233,405 (0%) | 0% | 503.5 | 375,618 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 1,562 | 6,520 (0%) | 0% | 503.5 | 786,483 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 3,148 | 8,082 (0%) | 0% | 0 | Common Stock | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 3,148 | 0 | - | - | Performance Stock Units - 2-28-2023 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 335 | 5,637 (0%) | 0% | 503.5 | 168,676 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 752 | 0 | - | - | Restricted Stock Units | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 10,773 | 0 | - | - | Performance Stock Units - 2-28-2023 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 4,800 | 11,610 (0%) | 0% | 503.5 | 2,416,848 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 10,773 | 16,410 (0%) | 0% | 0 | Common Stock | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 752 | 5,972 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 877 | 2,776 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 877 | 0 | - | - | Restricted Stock Units - 2-28-2022 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 8,378 | 0 | - | - | Performance Stock Units - 2-28-2023 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 4,155 | 6,564 (0%) | 0% | 503.5 | 2,092,084 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2026 | 8,378 | 10,719 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 28 Feb 2026 | 435 | 2,341 (0%) | 0% | 503.5 | 219,027 | Common Stock |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 28 Feb 2026 | 8,378 | 0 | - | - | Performance Stock Units - 2-28-2023 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 28 Feb 2026 | 626 | 0 | - | - | Restricted Stock Units - 2-28-2022 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 28 Feb 2026 | 626 | 2,551 (0%) | 0% | 0 | Common Stock | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 28 Feb 2026 | 311 | 2,240 (0%) | 0% | 503.5 | 156,592 | Common Stock | |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 28 Feb 2026 | 8,378 | 10,618 (0%) | 0% | 0 | Common Stock | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 28 Feb 2026 | 4,155 | 6,463 (0%) | 0% | 503.5 | 2,092,084 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 1,002 | 1,411 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 1,002 | 0 | - | - | Restricted Stock Units | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 8,378 | 0 | - | - | Performance Stock Units - 2-28-2023 | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 4,155 | 5,137 (0%) | 0% | 503.5 | 2,092,084 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 8,378 | 9,292 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 497 | 914 (0%) | 0% | 503.5 | 250,244 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2026 | 2,345 | 409 (0%) | 0% | 499.7 | 1,171,820 | Common Stock | |
| Fredrik C. Widman | VP Corporate Controller | Sale of securities on an exchange or to another person at price $ 499.71 per share. | 27 Feb 2026 | 249 | 909 (0%) | 0% | 499.7 | 124,428 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 468 | 1,377 (0%) | 0% | 0 | Common Stock | |
| Fredrik C. Widman | VP Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 503.51 per share. | 27 Feb 2026 | 233 | 1,144 (0%) | 0% | 503.5 | 117,318 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Sale of securities on an exchange or to another person at price $ 487.18 per share. | 27 Feb 2026 | 118 | 1,026 (0%) | 0% | 487.2 | 57,487 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 468 | 0 | - | - | Restricted Stock Units | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 4,960 | 9,920 | - | - | Restricted Stock Units - 2-26-2024 | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 3,433 | 10,299 | - | - | Restricted Stock Units - 2-26-2025 | |
| Gary S. Guthart | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 2,460 | 7,521 (0%) | 0% | 506.2 | 1,245,178 | Common Stock |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 4,960 | 9,981 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 3,433 | 10,954 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 1,703 | 9,251 (0%) | 0% | 506.2 | 862,008 | Common Stock |
| Gary S. Guthart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 8,778 | 26,334 | - | - | Performance Stock Units - 2-28-2023 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,488 | 4,463 | - | - | Restricted Stock Units - 2-26-2025 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,908 | 3,815 | - | - | Restricted Stock Units - 2-26-2024 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 3,591 | 10,773 | - | - | Performance Stock Units - 2-28-2023 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 738 | 9,557 (0%) | 0% | 506.2 | 373,553 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,488 | 10,295 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 900 | 8,807 (0%) | 0% | 506.2 | 455,553 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,908 | 9,707 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 6,720 | 6,720 | - | - | Restricted Stock Units - 2-26-2026 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 4,788 | 14,363 | - | - | Performance Stock Units - 2-28-2023 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 3,816 | 233,386 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 1,892 | 231,494 (0%) | 0% | 506.2 | 957,674 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 2,289 | 233,783 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 3,816 | 7,631 | - | - | Restricted Stock Units - 2-26-2024 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 3,018 | 9,052 | - | - | Performance Stock Units - 6-12-2023 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 2,289 | 6,866 | - | - | Restricted Stock Units - 2-26-2025 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 1,135 | 232,648 (0%) | 0% | 506.2 | 574,503 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 13,441 | 13,441 | - | - | Restricted Stock Units - 2-26-2026 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 916 | 2,746 | - | - | Restricted Stock Units - 2-26-2025 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,526 | 3,052 | - | - | Restricted Stock Units - 2-26-2024 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 1,050 | 3,148 | - | - | Performance Stock Units - 2-28-2023 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 455 | 4,934 (0%) | 0% | 506.2 | 230,307 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 916 | 5,389 (0%) | 0% | 0 | Common Stock | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 757 | 4,473 (0%) | 0% | 506.2 | 383,171 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,526 | 5,230 (0%) | 0% | 0 | Common Stock | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 3,584 | 3,584 | - | - | Restricted Stock Units - 2-26-2026 | |
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 3,052 | 3,053 | - | - | Restricted Stock Units - 2-26-2024 | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 2,793 | 8,378 | - | - | Performance Stock Units - 2-28-2023 | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 795 | 2,754 (0%) | 0% | 506.2 | 402,405 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 1,602 | 3,549 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 1,514 | 1,947 (0%) | 0% | 506.2 | 766,341 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 3,052 | 3,461 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2026 | 1,602 | 0 | - | - | Restricted Stock Units - 2-26-2025 | ||
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 378 | 1,133 | - | - | Restricted Stock Units - 2-26-2025 | |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 611 | 1,220 | - | - | Restricted Stock Units - 2-26-2024 | |
| Fredrik C. Widman | VP Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 188 | 1,158 (0%) | 0% | 506.2 | 95,160 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 378 | 1,346 (0%) | 0% | 0 | Common Stock | |
| Fredrik C. Widman | VP Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 303 | 968 (0%) | 0% | 506.2 | 153,370 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 611 | 1,271 (0%) | 0% | 0 | Common Stock | |
| Fredrik C. Widman | VP Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 1,627 | 1,627 | - | - | Restricted Stock Units - 2-26-2026 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 4,032 | 4,032 | - | - | Restricted Stock Units - 2-26-2026 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,030 | 3,090 | - | - | Restricted Stock Units - 2-26-2025 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,717 | 3,434 | - | - | Restricted Stock Units - 2-26-2024 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 3,591 | 10,773 | - | - | Performance Stock Units - 2-28-2023 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 459 | 5,220 (0%) | 0% | 506.2 | 232,332 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,030 | 5,679 (0%) | 0% | 0 | Common Stock | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 765 | 4,649 (0%) | 0% | 506.2 | 387,220 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,717 | 5,414 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,622 | 3,243 | - | - | Restricted Stock Units - 2-26-2024 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 973 | 2,918 | - | - | Restricted Stock Units - 2-26-2025 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 4,928 | 4,928 | - | - | Restricted Stock Units - 2-26-2026 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 1,622 | 2,214 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 805 | 1,409 (0%) | 0% | 506.2 | 407,467 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 973 | 2,382 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 506.17 per share. | 26 Feb 2026 | 483 | 1,899 (0%) | 0% | 506.2 | 244,480 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 2,793 | 8,378 | - | - | Performance Stock Units - 2-28-2023 | |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 687 | 2,263 (0%) | 0% | 0 | Common Stock | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 687 | 2,059 | - | - | Restricted Stock Units - 2-26-2025 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 1,622 | 3,243 | - | - | Restricted Stock Units - 2-26-2024 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 2,793 | 8,378 | - | - | Performance Stock Units - 2-28-2023 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 341 | 1,922 (0%) | 0% | 506.2 | 172,604 | Common Stock | |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 4,480 | 4,480 | - | - | Restricted Stock Units - 2-26-2026 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 1,622 | 2,207 (0%) | 0% | 0 | Common Stock | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 26 Feb 2026 | 631 | 1,576 (0%) | 0% | 506.2 | 319,393 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 1,077 | 8,295 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 496 | 7,799 (0%) | 0% | 492.8 | 244,449 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 1,077 | 1,077 | - | - | Restricted Stock Units | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 1,077 | 4,189 (0%) | 0% | 0 | Common Stock | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 1,077 | 1,077 | - | - | Restricted Stock Units | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 492 | 3,697 (0%) | 0% | 492.8 | 242,477 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 838 | 1,025 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 838 | 838 | - | - | Restricted Stock Units - 2-28-2023 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 433 | 592 (0%) | 0% | 492.8 | 213,400 | Common Stock |
| Gary S. Guthart | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 1,306 | 5,021 (0%) | 0% | 492.8 | 643,649 | Common Stock |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 2,633 | 6,327 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 2,633 | 2,633 | - | - | Restricted Stock Units | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 1,436 | 1,436 | - | - | Restricted Stock Units - 2-28-2023 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 1,436 | 230,294 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 724 | 229,570 (0%) | 0% | 492.8 | 356,816 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 315 | 3,876 (0%) | 0% | 0 | Common Stock | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 315 | 314 | - | - | Restricted Stock Units | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 172 | 3,704 (0%) | 0% | 492.8 | 84,768 | Common Stock |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 10 Feb 2026 | 838 | 838 | - | - | Restricted Stock Units - 2-28-2023 | ||
| Iman Jeddi | SVP & GM da Vinci Platforms & | 10 Feb 2026 | 309 | 585 (0%) | 0% | 492.8 | 152,288 | Common Stock | |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 10 Feb 2026 | 838 | 894 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 105 | 935 (0%) | 0% | 229.4 | 24,086 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 838 | 1,247 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 838 | 838 | - | - | Restricted Stock Units | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 105 | 1,257 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 421 | 409 (0%) | 0% | 495.0 | 208,378 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 105 | 830 (0%) | 0% | 494.6 | 51,938 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Feb 2026 | 417 | 830 (0%) | 0% | 492.8 | 205,514 | Common Stock | |
| Fredrik C. Widman | VP Corporate Controller | Sale of securities on an exchange or to another person at price $ 494.96 per share. | 10 Feb 2026 | 133 | 660 (0%) | 0% | 495.0 | 65,830 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.84 per share. | 10 Feb 2026 | 302 | 793 (0%) | 0% | 492.8 | 148,838 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 567 | 567 | - | - | Restricted Stock Units | |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2026 | 567 | 1,095 (0%) | 0% | 0 | Common Stock | |
| Keith R. Leonard | Director | Other type of transaction at price $ 0.00 per share. | 29 Jan 2026 | 369 | 370 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 17,556 | 17,556 | - | - | Performance Stock Units - 2-28-2023 | |
| Gary S. Guthart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 8,267 | 8,267 | - | - | Performance Stock Units - 2-26-2024 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 7,182 | 7,182 | - | - | Performance Stock Units - 2-28-2023 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 3,180 | 3,180 | - | - | Performance Stock Units - 2-26-2024 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 9,575 | 9,575 | - | - | Performance Stock Units - 2-28-2023 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 6,360 | 6,360 | - | - | Performance Stock Units - 2-26-2024 | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 6,034 | 6,034 | - | - | Performance Stock Units - 6-12-2023 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 2,098 | 2,098 | - | - | Performance Stock Units - 2-28-2023 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 2,543 | 2,543 | - | - | Performance Stock Units - 2-26-2024 | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Jan 2026 | 126 | 0 (0%) | 0% | 520.0 | 65,523 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Jan 2026 | 126 | 125 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Jan 2026 | 5,585 | 5,585 | - | - | Performance Stock Units - 2-28-2023 | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Jan 2026 | 126 | 126 (0%) | 0% | 208.9 | 26,321 | Common Stock | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 7,182 | 7,182 | - | - | Performance Stock Units - 2-28-2023 | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 2,861 | 2,861 | - | - | Performance Stock Units - 2-26-2024 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 2,702 | 2,702 | - | - | Performance Stock Units - 2-26-2024 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 5,585 | 5,585 | - | - | Performance Stock Units - 2-28-2023 | |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 174.26 per share. | 27 Jan 2026 | 25,500 | 28,194 (0%) | 0% | 174.3 | 4,443,546 | Common Stock |
| Gary S. Guthart | Director | Sale of securities on an exchange or to another person at price $ 530.10 per share. | 27 Jan 2026 | 24,500 | 3,694 (0%) | 0% | 530.1 | 12,987,403 | Common Stock |
| Gary S. Guthart | Director | Sale of securities on an exchange or to another person at price $ 531.53 per share. | 27 Jan 2026 | 1,400 | 15,720 (0%) | 0% | 531.5 | 744,140 | Common Stock |
| Gary S. Guthart | Director | Sale of securities on an exchange or to another person at price $ 531.52 per share. | 27 Jan 2026 | 1,400 | 15,720 (0%) | 0% | 531.5 | 744,129 | Common Stock |
| Gary S. Guthart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2026 | 25,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Jan 2026 | 105 | 105 (0%) | 0% | 229.4 | 24,086 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Jan 2026 | 105 | 0 (0%) | 0% | 532.6 | 55,924 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Jan 2026 | 125 | 125 (0%) | 0% | 208.9 | 26,113 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Jan 2026 | 125 | 0 (0%) | 0% | 532.6 | 66,576 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Jan 2026 | 125 | 251 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Jan 2026 | 105 | 1,362 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Mark P. Brosius | See Remarks | Sale of securities on an exchange or to another person at price $ 548.49 per share. | 15 Dec 2025 | 464 | 131 (0%) | 0% | 548.5 | 254,499 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.64 per share. | 12 Dec 2025 | 4,500 | 5,407 (0%) | 0% | 79.6 | 358,370 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 547.36 per share. | 12 Dec 2025 | 4,500 | 907 (0%) | 0% | 547.4 | 2,463,120 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 548.49 per share. | 12 Dec 2025 | 464 | 443 (0%) | 0% | 548.5 | 254,499 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 4,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark P. Brosius | See Remarks | Sale of securities on an exchange or to another person at price $ 547.36 per share. | 12 Dec 2025 | 312 | 595 (0%) | 0% | 547.4 | 170,776 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Dec 2025 | 104 | 0 (0%) | 0% | 559.9 | 58,230 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Dec 2025 | 104 | 1,467 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Dec 2025 | 104 | 104 (0%) | 0% | 229.4 | 23,857 | Common Stock | |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.52 per share. | 01 Dec 2025 | 25,500 | 25,500 (0%) | 0% | 139.5 | 3,557,760 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 25,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 570.89 per share. | 01 Dec 2025 | 22,806 | 2,694 (0%) | 0% | 570.9 | 13,019,722 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | 01 Dec 2025 | 125 | 125 (0%) | 0% | 208.9 | 26,113 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 01 Dec 2025 | 125 | 376 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 01 Dec 2025 | 125 | 0 (0%) | 0% | 569.0 | 71,124 | Common Stock | |
| Craig H. Barratt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Craig H. Barratt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.32 per share. | 12 Nov 2025 | 750 | 750 (0%) | 0% | 71.3 | 53,492 | Common Stock |
| Craig H. Barratt | Director | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 12 Nov 2025 | 750 | 0 (0%) | 0% | 580 | 435,000 | Common Stock |
| Keith R. Leonard | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 1,606 | 739 (0%) | 0% | 0 | Common Stock | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 12 Nov 2025 | 4,731 | 3,056 (0%) | 0% | 580 | 2,743,980 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 12 Nov 2025 | 2,901 | 7,787 (0%) | 0% | 580 | 1,682,580 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 177.99 per share. | 12 Nov 2025 | 2,901 | 10,688 (0%) | 0% | 178.0 | 516,339 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 12 Nov 2025 | 2,898 | 7,787 (0%) | 0% | 580 | 1,680,840 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 242.34 per share. | 12 Nov 2025 | 2,898 | 10,685 (0%) | 0% | 242.3 | 702,292 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 12 Nov 2025 | 2,565 | 7,787 (0%) | 0% | 580 | 1,487,700 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 245.60 per share. | 12 Nov 2025 | 2,565 | 10,352 (0%) | 0% | 245.6 | 629,964 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Sale of securities on an exchange or to another person at price $ 580.00 per share. | 12 Nov 2025 | 636 | 7,787 (0%) | 0% | 580 | 368,880 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 347.42 per share. | 12 Nov 2025 | 636 | 8,423 (0%) | 0% | 347.4 | 220,957 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 2,901 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 2,898 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 636 | 1,929 | - | - | Non-Qualified Stock Option (right to buy) | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 2,565 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Nov 2025 | 105 | 0 (0%) | 0% | 560 | 58,800 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Nov 2025 | 105 | 1,571 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 10 Nov 2025 | 105 | 105 (0%) | 0% | 229.4 | 24,086 | Common Stock | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 208.90 per share. | 10 Nov 2025 | 2,202 | 7,960 (0%) | 0% | 208.9 | 459,998 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 575.00 per share. | 10 Nov 2025 | 2,202 | 5,758 (0%) | 0% | 575 | 1,266,150 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 2,202 | 2,115 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 1,298 | 6,602 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 229.39 per share. | 10 Nov 2025 | 1,298 | 7,056 (0%) | 0% | 229.4 | 297,748 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 575.00 per share. | 10 Nov 2025 | 1,298 | 5,758 (0%) | 0% | 575 | 746,350 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.46 per share. | 05 Nov 2025 | 159 | 632 (0%) | 0% | 59.5 | 9,454 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 159 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Fredrik C. Widman | VP Corporate Controller | Sale of securities on an exchange or to another person at price $ 550.00 per share. | 05 Nov 2025 | 159 | 473 (0%) | 0% | 550 | 87,450 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 1,908 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Fredrik C. Widman | VP Corporate Controller | Sale of securities on an exchange or to another person at price $ 550.00 per share. | 05 Nov 2025 | 1,908 | 473 (0%) | 0% | 550 | 1,049,400 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.00 per share. | 05 Nov 2025 | 1,908 | 2,381 (0%) | 0% | 77.0 | 146,914 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Nov 2025 | 5,454 | 228,802 (0%) | 0% | 0 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 5,030 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 1,379 | 626 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 125 | 501 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 1,153 | 1,676 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 5,030 | 5,383 (0%) | 0% | 242.3 | 1,218,954 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 5,030 | 353 (0%) | 0% | 548.4 | 2,758,580 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 1,153 | 1,506 (0%) | 0% | 229.4 | 264,487 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 1,153 | 353 (0%) | 0% | 548.4 | 632,334 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 1,379 | 1,732 (0%) | 0% | 208.9 | 288,073 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 1,379 | 353 (0%) | 0% | 548.4 | 756,279 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 125 | 125 (0%) | 0% | 208.9 | 26,113 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 28 Oct 2025 | 125 | 0 (0%) | 0% | 543 | 67,875 | Common Stock | |
| Craig H. Barratt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.32 per share. | 24 Oct 2025 | 2,193 | 2,193 (0%) | 0% | 71.3 | 156,412 | Common Stock |
| Craig H. Barratt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2025 | 2,193 | 750 | - | - | Non-Qualified Stock Option (right to buy) | |
| Craig H. Barratt | Director | Sale of securities on an exchange or to another person at price $ 548.01 per share. | 24 Oct 2025 | 2,193 | 0 (0%) | 0% | 548.0 | 1,201,786 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2025 | 36,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 547.56 per share. | 24 Oct 2025 | 28,800 | 27,027 (0%) | 0% | 547.6 | 15,769,644 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.49 per share. | 24 Oct 2025 | 36,000 | 55,827 (0%) | 0% | 109.5 | 3,941,482 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 546.35 per share. | 24 Oct 2025 | 1,400 | 17,120 (0%) | 0% | 546.4 | 764,890 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 546.18 per share. | 24 Oct 2025 | 1,400 | 17,120 (0%) | 0% | 546.2 | 764,658 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Sale of securities on an exchange or to another person at price $ 547.55 per share. | 24 Oct 2025 | 24,500 | 234,256 (0%) | 0% | 547.6 | 13,414,980 | Common Stock |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2025 | 27,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.64 per share. | 24 Oct 2025 | 27,000 | 258,756 (0%) | 0% | 79.6 | 2,150,221 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2025 | 2,612 | 2,612 | - | - | Restricted Stock Units | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Payment of exercise price or tax liability using portion of securities received from the company at price $ 443.76 per share. | 10 Oct 2025 | 1,296 | 3,561 (0%) | 0% | 443.8 | 575,113 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2025 | 2,612 | 4,857 (0%) | 0% | 0 | Common Stock | |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 470.11 per share. | 03 Sep 2025 | 336 | 1,074 (0%) | 0% | 470.1 | 157,957 | Common Stock |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 440.69 per share. | 03 Sep 2025 | 335 | 739 (0%) | 0% | 440.7 | 147,631 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 36,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.64 per share. | 29 Aug 2025 | 36,000 | 49,187 (0%) | 0% | 79.6 | 2,866,961 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 472.49 per share. | 29 Aug 2025 | 29,360 | 19,827 (0%) | 0% | 472.5 | 13,872,227 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.46 per share. | 28 Jul 2025 | 7,893 | 21,080 (0%) | 0% | 59.5 | 469,335 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2025 | 7,893 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary S. Guthart | Director, Executive Chair of the Board o | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Jul 2025 | 10,500 | 1,204,863 (1%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 495.24 per share. | 28 Jul 2025 | 1,400 | 18,520 (0%) | 0% | 495.2 | 693,337 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 495.23 per share. | 28 Jul 2025 | 1,400 | 18,520 (0%) | 0% | 495.2 | 693,326 | Common Stock |
| Gary S. Guthart | Director, Executive Chair of the Board o | Sale of securities on an exchange or to another person at price $ 498.64 per share. | 28 Jul 2025 | 7,893 | 13,187 (0%) | 0% | 498.6 | 3,935,756 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | 25 Jul 2025 | 4,500 | 353 (0%) | 0% | 492.5 | 2,216,160 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 25 Jul 2025 | 4,500 | 4,853 (0%) | 0% | 242.3 | 1,090,515 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 25 Jul 2025 | 4,500 | 5,030 | - | - | Non-Qualified Stock Option (right to buy) | ||
| David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 7,640 | 7,640 | - | - | Restricted Stock Units | |
| David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.15 per share. | 10 Jun 2025 | 674 | 231,756 (0%) | 0% | 526.1 | 354,625 | Common Stock |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 1,358 | 2,716 | - | - | Restricted Stock Units - 6-12-23 | |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 1,358 | 232,430 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 560.70 per share. | 05 Jun 2025 | 215 | 1,123 (0%) | 0% | 560.7 | 120,551 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 563.11 per share. | 05 Jun 2025 | 216 | 907 (0%) | 0% | 563.1 | 121,632 | Common Stock |
| David J. Rosa | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2025 | 851 | 231,072 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 552.07 per share. | 02 Jun 2025 | 215 | 1,338 (0%) | 0% | 552.1 | 118,695 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 550.68 per share. | 02 Jun 2025 | 215 | 1,553 (0%) | 0% | 550.7 | 118,396 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 549.06 per share. | 02 Jun 2025 | 215 | 1,768 (0%) | 0% | 549.1 | 118,048 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 563.80 per share. | 15 May 2025 | 20 | 1,983 (0%) | 0% | 563.8 | 11,276 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 560.00 per share. | 15 May 2025 | 22 | 2,003 (0%) | 0% | 560 | 12,320 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 551.95 per share. | 12 May 2025 | 22 | 2,069 (0%) | 0% | 552.0 | 12,143 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 563.00 per share. | 12 May 2025 | 22 | 2,025 (0%) | 0% | 563 | 12,386 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 561.68 per share. | 12 May 2025 | 22 | 2,047 (0%) | 0% | 561.7 | 12,357 | Common Stock |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 208.90 per share. | 02 May 2025 | 188 | 7,350 (0%) | 0% | 208.9 | 39,273 | Common Stock |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 270 | 2,962 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 188 | 940 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 269 | 2,963 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 188 | 940 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jamie E. Samath | See Remarks | Sale of securities on an exchange or to another person at price $ 527.95 per share. | 02 May 2025 | 915 | 7,162 (0%) | 0% | 527.9 | 483,074 | Common Stock |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 304.67 per share. | 02 May 2025 | 270 | 8,077 (0%) | 0% | 304.7 | 82,261 | Common Stock |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 290.33 per share. | 02 May 2025 | 188 | 7,807 (0%) | 0% | 290.3 | 54,582 | Common Stock |
| Jamie E. Samath | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 229.39 per share. | 02 May 2025 | 269 | 7,619 (0%) | 0% | 229.4 | 61,706 | Common Stock |
| Amal M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Craig H. Barratt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 750 | 750 | - | - | Restricted Stock Units | |
| Jami Dover Nachtsheim | Director | Sale of securities on an exchange or to another person at price $ 520.00 per share. | 01 May 2025 | 2,400 | 6,371 (0%) | 0% | 520 | 1,248,000 | Common Stock |
| Jami Dover Nachtsheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Jami Dover Nachtsheim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.49 per share. | 01 May 2025 | 2,400 | 8,771 (0%) | 0% | 90.5 | 217,187 | Common Stock |
| Jami Dover Nachtsheim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,400 | 2,235 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lewis Chew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Keith R. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Joseph C. Beery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Sreelakshmi Kolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Monica P. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 1,709 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 505.55 per share. | 30 Apr 2025 | 1,709 | 1,410 (0%) | 0% | 505.5 | 863,978 | Common Stock |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 295.92 per share. | 30 Apr 2025 | 1,709 | 3,119 (0%) | 0% | 295.9 | 505,727 | Common Stock |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 505.55 per share. | 30 Apr 2025 | 1,650 | 1,410 (0%) | 0% | 505.5 | 834,151 | Common Stock |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 171.20 per share. | 30 Apr 2025 | 1,650 | 3,060 (0%) | 0% | 171.2 | 282,480 | Common Stock |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 505.55 per share. | 30 Apr 2025 | 2,298 | 1,410 (0%) | 0% | 505.5 | 1,161,744 | Common Stock |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 171.07 per share. | 30 Apr 2025 | 2,298 | 3,708 (0%) | 0% | 171.1 | 393,126 | Common Stock |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 505.55 per share. | 30 Apr 2025 | 1,671 | 1,410 (0%) | 0% | 505.5 | 844,767 | Common Stock |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 286.55 per share. | 30 Apr 2025 | 1,671 | 3,081 (0%) | 0% | 286.6 | 478,831 | Common Stock |
| Amy L. Ladd | Director | Sale of securities on an exchange or to another person at price $ 505.55 per share. | 30 Apr 2025 | 1,448 | 1,410 (0%) | 0% | 505.5 | 732,030 | Common Stock |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 243.26 per share. | 30 Apr 2025 | 1,448 | 2,858 (0%) | 0% | 243.3 | 352,240 | Common Stock |
| Amy L. Ladd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 531 | 531 | - | - | Restricted Stock Units | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 1,671 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 1,448 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 1,650 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 2,298 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amal M. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Amal M. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 13,014 (0%) | 0% | 0 | Common Stock | |
| Craig H. Barratt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 1,043 | 27,198 (0%) | 0% | 0 | Common Stock | |
| Craig H. Barratt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 1,043 | 0 | - | - | Restricted Stock Units | |
| Mark J. Rubash | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 16,790 (0%) | 0% | 0 | Common Stock | |
| Mark J. Rubash | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Keith R. Leonard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Keith R. Leonard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 2,345 (0%) | 0% | 0 | Common Stock | |
| Joseph C. Beery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 3,110 (0%) | 0% | 0 | Common Stock | |
| Joseph C. Beery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Sreelakshmi Kolli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 979 (0%) | 0% | 0 | Common Stock | |
| Sreelakshmi Kolli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Amy L. Ladd | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 1,410 (0%) | 0% | 0 | Common Stock | |
| Monica P. Reed | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 2,345 (0%) | 0% | 0 | Common Stock | |
| Monica P. Reed | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Jami Dover Nachtsheim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 6,371 (0%) | 0% | 0 | Common Stock | |
| Jami Dover Nachtsheim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Lewis Chew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 783 (0%) | 0% | 0 | Common Stock | |
| Lewis Chew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 739 | 0 | - | - | Restricted Stock Units | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Sale of securities on an exchange or to another person at price $ 513.18 per share. | 25 Apr 2025 | 1,700 | 2,245 (0%) | 0% | 513.2 | 872,406 | Common Stock |
| Myriam J. Curet | EVP & Chief Medical Officer | 25 Apr 2025 | 4,000 | 9,530 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 25 Apr 2025 | 4,000 | 4,353 (0%) | 0% | 242.3 | 969,347 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 25 Apr 2025 | 4,000 | 353 (0%) | 0% | 513.2 | 2,052,720 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 2,068 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 119 | 5,224 (0%) | 0% | 513.2 | 61,068 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 119 | 5,343 (0%) | 0% | 229.4 | 27,297 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 119 | 5,224 (0%) | 0% | 513.2 | 61,068 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,412 (0%) | 0% | 208.9 | 39,273 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,224 (0%) | 0% | 513.2 | 96,478 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,412 (0%) | 0% | 290.3 | 54,582 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,224 (0%) | 0% | 515.9 | 96,991 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,412 (0%) | 0% | 208.9 | 39,273 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,224 (0%) | 0% | 512.9 | 96,425 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 119 | 2,634 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,412 (0%) | 0% | 290.3 | 54,582 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 1,880 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 2,068 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 119 | 2,634 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 119 | 5,343 (0%) | 0% | 304.7 | 36,256 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 5,224 (0%) | 0% | 513.2 | 96,478 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 25 Apr 2025 | 188 | 1,880 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 564 | 14,052 (0%) | 0% | 290.3 | 163,746 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 597 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 479 | 2,753 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 564 | 2,256 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 597 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 480 | 2,753 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 564 | 2,256 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 4,557 | 5,224 (0%) | 0% | 500 | 2,278,500 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 480 | 13,968 (0%) | 0% | 229.4 | 110,107 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 480 | 13,488 (0%) | 0% | 498.7 | 239,381 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 564 | 14,052 (0%) | 0% | 208.9 | 117,820 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 564 | 13,488 (0%) | 0% | 498.7 | 281,272 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 3,707 | 9,781 (0%) | 0% | 498.7 | 1,848,718 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 479 | 13,488 (0%) | 0% | 498.7 | 238,882 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 479 | 13,967 (0%) | 0% | 304.7 | 145,937 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 597 | 13,488 (0%) | 0% | 498.7 | 297,730 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 597 | 14,085 (0%) | 0% | 245.6 | 146,623 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 597 | 13,488 (0%) | 0% | 498.7 | 297,730 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 597 | 14,085 (0%) | 0% | 347.4 | 207,408 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 13 Mar 2025 | 564 | 13,488 (0%) | 0% | 498.7 | 281,272 | Common Stock | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 2,450 | 4,317 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 1,834 | 1,550 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 512.06 per share. | 11 Mar 2025 | 2,450 | 5,758 (0%) | 0% | 512.1 | 1,254,547 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 512.06 per share. | 11 Mar 2025 | 1,550 | 5,758 (0%) | 0% | 512.1 | 793,693 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 484.97 per share. | 11 Mar 2025 | 6,624 | 5,758 (0%) | 0% | 485.0 | 3,212,449 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 482.82 per share. | 11 Mar 2025 | 442 | 12,382 (0%) | 0% | 482.8 | 213,408 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Sale of securities on an exchange or to another person at price $ 485.96 per share. | 11 Mar 2025 | 1,834 | 12,824 (0%) | 0% | 486.0 | 891,245 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 177.99 per share. | 11 Mar 2025 | 1,834 | 14,658 (0%) | 0% | 178.0 | 326,428 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 177.99 per share. | 11 Mar 2025 | 1,550 | 7,308 (0%) | 0% | 178.0 | 275,879 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 208.90 per share. | 11 Mar 2025 | 2,450 | 8,208 (0%) | 0% | 208.9 | 511,805 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 1,550 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 533.18 per share. | 07 Mar 2025 | 489 | 2,091 (0%) | 0% | 533.2 | 260,725 | Common Stock |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.00 per share. | 05 Mar 2025 | 14,625 | 233,807 (0%) | 0% | 77.0 | 1,126,109 | Common Stock |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 14,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 14,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| David J. Rosa | Director, President | Sale of securities on an exchange or to another person at price $ 557.58 per share. | 05 Mar 2025 | 8,140 | 231,923 (0%) | 0% | 557.6 | 4,538,691 | Common Stock |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.46 per share. | 05 Mar 2025 | 14,625 | 240,063 (0%) | 0% | 59.5 | 869,635 | Common Stock |
| David J. Rosa | Director, President | Sale of securities on an exchange or to another person at price $ 557.47 per share. | 05 Mar 2025 | 8,369 | 225,438 (0%) | 0% | 557.5 | 4,665,452 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 563.69 per share. | 04 Mar 2025 | 492 | 3,564 (0%) | 0% | 563.7 | 277,335 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 554.17 per share. | 04 Mar 2025 | 492 | 3,072 (0%) | 0% | 554.2 | 272,652 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 558.95 per share. | 04 Mar 2025 | 492 | 2,580 (0%) | 0% | 558.9 | 275,003 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 468 | 1,516 (0%) | 0% | 0 | Common Stock | |
| Fredrik C. Widman | VP Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 468 | 468 | - | - | Restricted Stock Units | |
| Fredrik C. Widman | VP Corporate Controller | Sale of securities on an exchange or to another person at price $ 573.78 per share. | 28 Feb 2025 | 810 | 473 (0%) | 0% | 573.8 | 464,762 | Common Stock |
| Fredrik C. Widman | VP Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 28 Feb 2025 | 233 | 1,283 (0%) | 0% | 563.8 | 131,358 | Common Stock |
| Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,506 | 20,643 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 1,243 | 19,400 (0%) | 0% | 563.8 | 700,766 | Common Stock |
| Gary S. Guthart | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 6,213 | 13,187 (0%) | 0% | 563.8 | 3,502,703 | Common Stock |
| Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,506 | 2,506 | - | - | Restricted Stock Units | |
| Gary S. Guthart | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 12,530 | 18,137 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 752 | 752 | - | - | Restricted Stock Units | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 3,758 | 8,648 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 752 | 9,400 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 373 | 9,027 (0%) | 0% | 563.8 | 210,286 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 1,865 | 7,162 (0%) | 0% | 563.8 | 1,051,431 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 290.33 per share. | 27 Feb 2025 | 94 | 7,256 (0%) | 0% | 290.3 | 27,291 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Sale of securities on an exchange or to another person at price $ 566.94 per share. | 27 Feb 2025 | 94 | 7,162 (0%) | 0% | 566.9 | 53,292 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 208.90 per share. | 27 Feb 2025 | 94 | 7,256 (0%) | 0% | 208.9 | 19,637 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Sale of securities on an exchange or to another person at price $ 566.94 per share. | 27 Feb 2025 | 94 | 7,162 (0%) | 0% | 566.9 | 53,292 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 94 | 1,128 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 94 | 1,128 | - | - | Non-Qualified Stock Option (right to buy) | |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,504 | 1,503 | - | - | Restricted Stock Units | |
| David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 3,729 | 219,182 (0%) | 0% | 563.8 | 2,102,298 | Common Stock |
| David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 746 | 222,911 (0%) | 0% | 563.8 | 420,572 | Common Stock |
| David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,504 | 223,657 (0%) | 0% | 0 | Common Stock | |
| David J. Rosa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 7,518 | 222,153 (0%) | 0% | 0 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2025 | 1,002 | 6,367 (0%) | 0% | 0 | Common Stock | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2025 | 497 | 5,870 (0%) | 0% | 563.8 | 280,194 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2025 | 3,031 | 353 (0%) | 0% | 577.3 | 1,749,783 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2025 | 2,486 | 3,384 (0%) | 0% | 563.8 | 1,401,532 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2025 | 1,002 | 1,002 | - | - | Restricted Stock Units | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 27 Feb 2025 | 5,012 | 7,766 (0%) | 0% | 0 | Common Stock | ||
| Brian Miller | EVP & Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 5,638 | 15,054 (0%) | 0% | 0 | Common Stock | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,128 | 1,127 | - | - | Restricted Stock Units - 2-28-2022 | |
| Brian Miller | EVP & Chief Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,128 | 16,182 (0%) | 0% | 0 | Common Stock | |
| Brian Miller | EVP & Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 560 | 15,622 (0%) | 0% | 563.8 | 315,711 | Common Stock |
| Brian Miller | EVP & Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 2,798 | 12,824 (0%) | 0% | 563.8 | 1,577,428 | Common Stock |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 27 Feb 2025 | 2,961 | 13,488 (0%) | 0% | 563.8 | 1,669,323 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 27 Feb 2025 | 7,518 | 15,537 (0%) | 0% | 0 | Common Stock | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 27 Feb 2025 | 1,504 | 17,041 (0%) | 0% | 0 | Common Stock | ||
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 27 Feb 2025 | 592 | 16,449 (0%) | 0% | 563.8 | 333,752 | Common Stock | |
| Robert DeSantis | EVP & Chief Strategy & Corp Op | 27 Feb 2025 | 1,504 | 1,503 | - | - | Restricted Stock Units | ||
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 752 | 9,807 (0%) | 0% | 0 | Common Stock | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 752 | 752 | - | - | Restricted Stock Units | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 1,683 | 7,787 (0%) | 0% | 563.8 | 948,825 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 337 | 9,470 (0%) | 0% | 563.8 | 189,990 | Common Stock |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 3,758 | 9,055 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 2,175 | 4,548 (0%) | 0% | 563.8 | 1,226,200 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Sale of securities on an exchange or to another person at price $ 573.78 per share. | 27 Feb 2025 | 492 | 4,056 (0%) | 0% | 573.8 | 282,300 | Common Stock |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 877 | 877 | - | - | Restricted Stock Units - 2-28-2022 | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 4,385 | 6,281 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 877 | 7,158 (0%) | 0% | 0 | Common Stock | |
| Mark P. Brosius | SVP & Chief Mfg and Supply Cha | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 435 | 6,723 (0%) | 0% | 563.8 | 245,240 | Common Stock |
| Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 4,961 | 8,067 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 2,460 | 5,607 (0%) | 0% | 573.7 | 1,411,400 | Common Stock |
| Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,030 | 0 | - | - | Restricted Stock Units | |
| Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 4,961 | 14,880 | - | - | Restricted Stock Units - 2-26-2024 | |
| Gary S. Guthart | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 13,732 | 13,732 | - | - | Restricted Stock Units - 2-26-2025 | |
| Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,030 | 4,609 (0%) | 0% | 0 | Common Stock | |
| Gary S. Guthart | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 1,503 | 3,106 (0%) | 0% | 573.7 | 862,331 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 54 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,281 | 0 | - | - | Restricted Stock Units | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,951 | 5,951 | - | - | Restricted Stock Units - 2-26-2025 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,908 | 5,723 | - | - | Restricted Stock Units - 2-26-2024 | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,281 | 4,563 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 635 | 3,928 (0%) | 0% | 573.7 | 364,325 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,908 | 5,836 (0%) | 0% | 0 | Common Stock | |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 946 | 4,890 (0%) | 0% | 573.7 | 542,758 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 347.43 per share. | 26 Feb 2025 | 54 | 4,944 (0%) | 0% | 347.4 | 18,761 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Sale of securities on an exchange or to another person at price $ 570.85 per share. | 26 Feb 2025 | 54 | 4,890 (0%) | 0% | 570.9 | 30,826 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 245.59 per share. | 26 Feb 2025 | 54 | 4,944 (0%) | 0% | 245.6 | 13,262 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Sale of securities on an exchange or to another person at price $ 570.85 per share. | 26 Feb 2025 | 54 | 4,890 (0%) | 0% | 570.9 | 30,826 | Common Stock |
| Jamie E. Samath | EVP & CFO & Enterprise Technol | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 54 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,527 | 4,578 | - | - | Restricted Stock Units - 2-26-2024 | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,527 | 4,703 (0%) | 0% | 0 | Common Stock | |
| Gary H. Loeb | EVP & Chief Legal and Complian | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 758 | 3,945 (0%) | 0% | 573.7 | 434,895 | Common Stock |
| Gary H. Loeb | EVP & Chief Legal and Complian | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 3,662 | 3,662 | - | - | Restricted Stock Units - 2-26-2025 | |
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2025 | 848 | 1,215 (0%) | 0% | 573.7 | 486,532 | Common Stock | |
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2025 | 1,602 | 1,602 | - | - | Restricted Stock Units - 2-26-2025 | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2025 | 3,053 | 6,105 | - | - | Restricted Stock Units - 2-26-2024 | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2025 | 1,710 | 0 | - | - | Restricted Stock Units | ||
| Myriam J. Curet | EVP & Chief Medical Officer | 26 Feb 2025 | 2,401 | 353 (0%) | 0% | 581 | 1,394,981 | Common Stock |